All week 48 analyses were prespecified in the statistical analysis plan, and all week 72 analyses were considered post hoc
The short answer is an unequivocal, absolute yes
Weight-loss results are self-reported, not typical, and vary based on starting weight, adherence, and individual health
A 2023 trial in patients with fatty liver disease went further, showing that semaglutide decreased both VAT and hepatic fat, underscoring how central fat loss links directly to organ health
Here is what we want you to know: weight is shaped by many factors, including your health history, hormones, metabolism, daily habits, stress, sleep, and other medical conditions
Why freezing destroys compounded semaglutide Do not freeze it